Protein aggregation is an important concern when developing and manufacturing biotherapeutics since these subvisible aggregate particles have been associated with the adverse drug reactions. Protein aggregates may provoke adverse events through an unwanted immune response. And, regardless of mechanism of reaction, subvisible particle contamination has been a concern for manufacturers and regulators.
Therefore, it is important to quantify protein aggregation and particle formulation due to various stresses such as temperature, shear, high concentration and time. Values for particle concentration and size distribution allow direct comparison of samples and treatments. Such data is needed to guide formulation development, evaluate handling requirements, and monitor product quality.
氅�韹� 霠堨澊鞝� 雮橂吀 鞛呾瀽 於旍爜 攵勳劃旮�
蓝鲸体育直播鞝滍拡鞚� 鞛愳劯頃� 鞝曤炒毳� 鞗愴晿鞁滊┐, 鞎勲灅鞚� 鞏戩嫕鞐� 雮挫毄鞚� 鞛呺牓鞚� 攵�韮侂摐毽诫媹雼�.
